Codexis Inc. Overview

Codexis, Inc., a biotechnology company headquartered in Redwood City, United States, operates within the Health Care sector, specifically in the Life Sciences Tools & Services industry. The company is publicly traded on the Nasdaq with its financials reported in USD.

Recent Financial Performance

As of July 2, 2025, Codexis Inc. closed at a price of $2.77. Over the past year, the company’s stock has experienced significant volatility. The 52-week high was recorded at $6.08 on December 10, 2024, while the 52-week low was $1.90 on April 6, 2025.

Business Focus

Codexis specializes in the development of biocatalysts, which are crucial for the pharmaceutical and fine chemicals industries. The company’s technology is designed to facilitate the scale-up and implementation of biocatalytic solutions, aiding customers in enhancing their manufacturing processes globally.

Industry Impact

By providing advanced biocatalytic technologies, Codexis plays a pivotal role in improving the efficiency and sustainability of manufacturing processes in the pharmaceutical and fine chemicals sectors. This focus on innovation positions Codexis as a key player in the biotechnology field, contributing to advancements in drug development and chemical production.

Conclusion

Codexis Inc. continues to leverage its expertise in biocatalysis to support the pharmaceutical and fine chemicals industries. Despite recent stock price fluctuations, the company remains committed to delivering cutting-edge solutions that enhance manufacturing processes worldwide.